3-Methylpyridine

3-Methylpyridine

SCHEMBL7852996

Cc1cccnc1.O=S(=O)(O)Cl

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAPRT Q6XQN6 1/20 0.52
▸ CYP2A6 P11509 2/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ PTGS2 P35354 3/20 0.43
▸ EGFR P00533 1/20 0.43
▸ ALDH1A1 P00352 4/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ NAMPT P43490 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ APP P05067 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ HCAR3 P49019 1/20 0.39
▸ HCAR2 Q8TDS4 1/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ CYP19A1 P11511 1/20 0.39
▸ TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
3-Methylpyridine SCHEMBL27365504 0.92 CYP2A6 (0.48) NAPRTCYP2A6CYP3A4PTGS2EGFR
3-Methylpyridine SCHEMBL407437 0.92 NAPRT (0.55) NAPRTCYP2A6CYP3A4PTGS2EGFR
3-Methylpyridine SCHEMBL9336426 0.86 NAPRT (0.50) NAPRTCYP2A6CYP3A4PTGS2EGFR
3-Methylpyridine SCHEMBL22235087 0.83 CYP2A6 (0.48) CYP2A6CYP3A4PTGS2EGFRALDH1A1
Trifluoromethanesulfonic Acid SCHEMBL30580567 0.83 NAPRT (0.47) NAPRTCYP2A6CYP3A4PTGS2EGFR
Trifluoromethanesulfonic Acid SCHEMBL27649544 0.83 NAPRT (0.47) NAPRTCYP2A6CYP3A4PTGS2EGFR
3-Methylpyridine SCHEMBL29046452 0.83 — —
3-Methylpyridine SCHEMBL820155 0.82 CYP2A6 (0.54) CYP2A6CYP3A4ALDH1A1NPC1RAB9A
3-Methylpyridine SCHEMBL29361018 0.82 — —
3-Methylpyridine SCHEMBL10530 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0713875-B1 Sulfonamides HOFFMANN LA ROCHE (CH) 2001-03-21 — — EP disclosed
US-5837708-A CARDIOVASCULAR DISORDERS OF HYPERTENSION, ISCHEMIA, ANGINA PECTORIS AND VASOSPASMS HOFFMANN-LA ROCHE INC. (US) 1998-11-17 — — US disclosed
WO-1996016963-A1 SULFONAMIDES AND THEIR USE AS MEDICAMENTS F. HOFFMANN-LA ROCHE AG (CH) 1996-06-06 — — WO disclosed
EP-0713875-A1 Sulfonamides F. Hoffmann-La Roche AG (CH) 1996-05-29 — — EP disclosed
Send feedback